Hans Gelderblom - Concepedia

Author

Hans Gelderblom

Also Known As

A.J. Gelderblom, Bardia, Aditya, Cathrien A. Bruggeman, Eike Jakob Spruth, GELDERBLOM, H, Gelderblom, H., Gelderblom, Hans, Grimer, Robert, H GELDERBLOM, H Gelderblom

1.3K

Publications

52.8K

Citations

106

H-Index

242

Concepts

All Affiliations

Leiden University Medical Center Radboud University Nijmegen The Netherlands Cancer Institute Centre Léon Bérard Radboud University Medical Center

About

Hans Gelderblom is an author at Leiden University Medical Center specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	66	216	21K
2	Health Sciences	21	33	3.9K
3	Natural Sciences	4	4	176
4	Engineering	2	2	139
5	Education	1	1	80

Hans Gelderblom

461

Publications

39.8K

Citations

H-Index

Page 1

	Year	Citations
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial Winette T.A. van der Graaf, Jean‐Yves Blay, Sant P. Chawla, The Lancet Metastatic Soft-tissue SarcomaPlacebo-controlled Phase 3MedicineMetronomic TherapyClinical Trials	2012	2K
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, N. Abecassis, Sebastian Bauer, Annals of Oncology	2018	1.6K
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial George D. Demetri, Peter Reichardt, Yoon‐Koo Kang, The Lancet Gastrointestinal OncologyMedicinePharmacologyPathologyPharmacotherapy	2012	1.4K
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial Ian Judson, Jaap Verweij, Hans Gelderblom, The Lancet Oncology Metastatic Soft-tissue SarcomaVersus Intensified DoxorubicinOncologyMalignant DiseasePathology	2014	1.1K
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ Alessandro Gronchi, Aisha Miah, Angelo Paolo Dei Tos, Annals of Oncology Surgical OncologySoft Tissue SurgeryVisceral SarcomasSurgical PathologyHistopathology	2021	879
Combination Chemotherapy in Advanced Adrenocortical Carcinoma Massimo Terzolo, Bruno Allolio, Éric Baudin, New England Journal of Medicine	2012	845
A very small porcine virus with circular single-stranded DNA Ilse Tischer, Hans Gelderblom, W. Vettermann, Nature Dna ReplicationVirologySmall Porcine VirusSwine VirusVirus Structure	1982	788
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial Patrick Schöffski, Sant P. Chawla, Robert G. Maki, The Lancet OncologyMetronomic TherapyPharmacologyAdvanced LiposarcomaEribulin Versus Dacarbazine	2016	753
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, N. Abecassis, Sebastian Bauer, Annals of Oncology	2018	747
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Pancras C.W. Hogendoorn, Nick Athanasou, S. Bielack, Annals of Oncology Bone SarcomasSurgical OncologyMedicineOrthopaedic SurgeryRadiology	2010	716

Page 1